Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Genetics. 2013 Mar;193(3):865-76. doi: 10.1534/genetics.112.149088. Epub 2013 Jan 18.
Intraneuronal deposition of aggregated proteins in tauopathies, Parkinson disease, or familial encephalopathy with neuroserpin inclusion bodies (FENIB) leads to impaired protein homeostasis (proteostasis). FENIB represents a conformational dementia, caused by intraneuronal polymerization of mutant variants of the serine protease inhibitor neuroserpin. In contrast to the aggregation process, the kinetic relationship between neuronal proteostasis and aggregation are poorly understood. To address aggregate formation dynamics, we studied FENIB in Caenorhabditis elegans and mice. Point mutations causing FENIB also result in aggregation of the neuroserpin homolog SRP-2 most likely within the ER lumen in worms, recapitulating morphological and biochemical features of the human disease. Intriguingly, we identified conserved protein quality control pathways to modulate protein aggregation both in worms and mice. Specifically, downregulation of the unfolded protein response (UPR) pathways in the worm favors mutant SRP-2 accumulation, while mice overexpressing a polymerizing mutant of neuroserpin undergo transient induction of the UPR in young but not in aged mice. Thus, we find that perturbations of proteostasis through impairment of the heat shock response or altered UPR signaling enhance neuroserpin accumulation in vivo. Moreover, accumulation of neuroserpin polymers in mice is associated with an age-related induction of the UPR suggesting a novel interaction between aging and ER overload. These data suggest that targets aimed at increasing UPR capacity in neurons are valuable tools for therapeutic intervention.
在神经原纤维缠结病、帕金森病或家族性伴神经丝氨酸蛋白酶抑制剂内含物的脑腱黄瘤病(FENIB)中,聚集蛋白在神经元内的沉积导致蛋白质平衡(蛋白稳态)受损。FENIB 代表一种构象性痴呆,由丝氨酸蛋白酶抑制剂神经丝氨酸蛋白酶抑制剂的突变体在神经元内聚合引起。与聚集过程相比,神经元蛋白稳态和聚集之间的动力学关系了解甚少。为了解析聚集形成的动态变化,我们在秀丽隐杆线虫和小鼠中研究了 FENIB。导致 FENIB 的点突变也很可能在蠕虫的内质网腔中引起神经丝氨酸蛋白酶抑制剂同源物 SRP-2 的聚集,再现了人类疾病的形态和生化特征。有趣的是,我们确定了保守的蛋白质质量控制途径,以调节蠕虫和小鼠中的蛋白质聚集。具体而言,下调蠕虫中的未折叠蛋白反应(UPR)途径有利于突变 SRP-2 的积累,而过表达聚合突变神经丝氨酸蛋白酶抑制剂的小鼠在年轻而非老年小鼠中经历 UPR 的短暂诱导。因此,我们发现通过热休克反应或改变 UPR 信号的蛋白稳态扰动增强了体内神经丝氨酸蛋白酶抑制剂的积累。此外,在小鼠中神经丝氨酸蛋白酶抑制剂聚合物的积累与 UPR 的年龄相关诱导有关,这表明衰老和内质网过载之间存在新的相互作用。这些数据表明,旨在增加神经元中 UPR 能力的靶标是治疗干预的有价值工具。